These data further confirm the key role of PTPRG, a gene described as a key regulator of cell differentiation in normal and in CML cells, acting as tumor suppressor in this context, a role supported by several studies performed in patients [15,16,20,21,53]. The gene discussed is PTPRG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.